-transparent.png){kind=logo}
Is it time to reconsider how higher valency pneumococcal conjugate vaccines are evaluated? 2024
Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia; Infection and Immunity, Murdoch Children's Research Institute, Melbourne, VIC, Australia. Electronic address: beth.temple@menzies.edu.au.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Beth Temple, and
Paul Licciardi
January 2020,
AIMS public health,
Beth Temple, and
Paul Licciardi
July 2021,
American journal of preventive medicine,
Beth Temple, and
Paul Licciardi
June 2024,
The Pediatric infectious disease journal,
Beth Temple, and
Paul Licciardi
February 2014,
Korean journal of pediatrics,
Beth Temple, and
Paul Licciardi
December 2023,
The Journal of infectious diseases,
Beth Temple, and
Paul Licciardi
June 2023,
Vaccines,
Beth Temple, and
Paul Licciardi
February 2022,
Expert review of vaccines,
Beth Temple, and
Paul Licciardi
June 2022,
Kidney international reports,
Beth Temple, and
Paul Licciardi
September 2015,
European journal of anaesthesiology,
Beth Temple, and
Paul Licciardi
August 2023,
medRxiv : the preprint server for health sciences,
